250 related articles for article (PubMed ID: 17112319)
21. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
22. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
23. EGFR signaling inhibits E2F1-induced apoptosis in vivo: implications for cancer therapy.
Ginsberg D
Sci STKE; 2007 Jan; 2007(371):pe4. PubMed ID: 17264315
[TBL] [Abstract][Full Text] [Related]
24. Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program.
Royzman I; Whittaker AJ; Orr-Weaver TL
Genes Dev; 1997 Aug; 11(15):1999-2011. PubMed ID: 9271122
[TBL] [Abstract][Full Text] [Related]
25. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.
DeGregori J; Leone G; Ohtani K; Miron A; Nevins JR
Genes Dev; 1995 Dec; 9(23):2873-87. PubMed ID: 7498785
[TBL] [Abstract][Full Text] [Related]
26. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis.
Bashari D; Hacohen D; Ginsberg D
Cell Signal; 2011 Jan; 23(1):65-70. PubMed ID: 20800677
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
28. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation.
Dilla T; Romero J; Sanstisteban P; Velasco JA
Oncogene; 2002 Apr; 21(15):2376-86. PubMed ID: 11948421
[TBL] [Abstract][Full Text] [Related]
29. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
30. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K; Sanchez B; Amati B
Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
[TBL] [Abstract][Full Text] [Related]
31. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity.
Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI
Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
34. Expression level is a key determinant of E2F1-mediated cell fate.
Shats I; Deng M; Davidovich A; Zhang C; Kwon JS; Manandhar D; Gordân R; Yao G; You L
Cell Death Differ; 2017 Apr; 24(4):626-637. PubMed ID: 28211871
[TBL] [Abstract][Full Text] [Related]
35. Cloning, expression pattern, and potential role of apoptosis inhibitor 5 in the termination of embryonic diapause and early embryo development of Artemia sinica.
Zhang S; Yao F; Jing T; Zhang M; Zhao W; Zou X; Sui L; Hou L
Gene; 2017 Sep; 628():170-179. PubMed ID: 28710039
[TBL] [Abstract][Full Text] [Related]
36. Alternate transcripts of the Drosophila "activator" E2F are necessary for maintenance of cell cycle exit during development.
Bradley-Gill MR; Kim M; Feingold D; Yergeau C; Houde J; Moon NS
Dev Biol; 2016 Mar; 411(2):195-206. PubMed ID: 26859702
[TBL] [Abstract][Full Text] [Related]
37. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
38. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
de la Luna S; Allen KE; Mason SL; La Thangue NB
EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
[TBL] [Abstract][Full Text] [Related]
39. The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
Gizard F; Nomiyama T; Zhao Y; Findeisen HM; Heywood EB; Jones KL; Staels B; Bruemmer D
Circ Res; 2008 Nov; 103(10):1155-63. PubMed ID: 18818403
[TBL] [Abstract][Full Text] [Related]
40. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
Johnson DG; Ohtani K; Nevins JR
Genes Dev; 1994 Jul; 8(13):1514-25. PubMed ID: 7958836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
